APP下载

促红细胞生成素联合养血益肾方在

2017-03-20周珂董扬洲周红霞王小玲陈

中国民族民间医药·下半月 2017年2期
关键词:血液透析疗效

周珂++董扬洲++周红霞++王小玲++陈毅君++付铁娇

【摘要】目的:观察养血益肾方对血液透析贫血患者的临床疗效。方法:将维持性血液透析贫血患者91例分为促红素组(E组)30例、养血益肾组(Y组)29例和强化组(E+Y组)32例,分别给予促红素、养血益肾方和促红素联合养血益肾方治疗8周,比较治疗前后各组的铁调素(Hepcidin)、血红蛋白(HGB)、铁蛋白(SF)。结果:E+Y组Hepcidin、HCT、HGB、SF等指标的改善优于E组和Y组(P<005),E组对Hepcidin和SF的改善优于Y组(P<005),而Y组对HCT和HGB的改善与E组无统计学差异(P>005)。结论:养血益肾方对血液透析贫血患者具有纠正贫血的作用,可能与其在一定程度上降低Hepcidin,提高SF有关,但更与直接提高HCT和HGB关系更密切。

【关键词】养血益肾;血液透析;贫血;疗效;Hepcidin

【中图分类号】R4595【文献标志码】 A【文章编号】1007-8517(2017)04-0124-03

Effect of Yangxue Yishen Decoction on Hepcidin and Ferroproteinin Hemodialysis Patients ZHOU Ke1DONG Yangzhou1ZHOU Hongxia1WANG Xiaoling1CHEN Yijun1FU Tiejiao2

1The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine,Changsha 410005,China;

2 Hongshan Community Health Service Center in Changsha, Changsha 410000,ChinaAbstract:Objective To observe the clinical effect of Yangxue Yishen Decoction on hemodialysis patients with anemia Methods 91 cases of maintenance hemodialysis patients with anemia were randomly divided into erythropoietin group(E group)30 cases, Yangxue Yishen Decoction group(Y group)29 cases and intensive group(E+Y group)32 cases,which were given erythropoietin essence, Yangxue Yishen Decoction, Yangxue Yishen Decoction and erythropoietin for 8 weeks Iron regulated hormone(hepcidin), hemoglobin(Hgb) and ferritin(SF) each group were compared before and after being treated ResultsThe improvement of Hepcidin, HCT, HGB, SF of E+Y group were better than those of E group and Y group(P<005) The improvement of SF and Hepcidin in E group was better than Y group(P<005), while the improvement of HCT and HGB in Y group was better than E group(P<005) Conclusion Mechanism of Yangxue Yishen Decoction correcting anemia in patients with hemodialysis may be related to decreasing hepcidin and improving the SF some extent, but improving HCT and HGB directly more closely

Keywords:Yangxue Yishen Decoction;Hemodialysis;Anemia;Curative Effect; Hepcidin

有统计显示,约有70%~90%维持性血液透析患者存在不同程度的贫血[1]。王艳丽研究显示[2],CKD1~5期患者贫血率分别为1923%、3823%、4875%、826%、977%,其中透析组CKD患者的贫血率高达9723%,而且肾功能与贫血发生率有显著相关性。积极纠正贫血对于慢性肾衰患者有积极意义。长期以来,中药对于肾性贫血的作用屡有报道[3-4]。笔者观察了自拟之养血益肾方对血液透析贫血患者的疗效和相关指标的变化,现报告如下。

1资料与方法

1.1一般資料选取2015年5月至2016年5月在湖南中医药大学第二附属医院维持性血液透析患者91例,分为促红素组(E组)、养血益肾组(Y组)和强化组(E+Y组),其中E组患者30例,Y组患者29例,E+Y组患者32例。E组中男性19例,女性11例;年龄38~67岁,平均(4234±1725)岁;病程7~13个月,平均(83±36)个月;原发病:慢性肾小球肾炎16例,糖尿病肾病9例,高尿酸性肾病3例,紫癜性肾病2例;贫血程度:轻度贫血17例,中度贫血10例,重度贫血3例。……

登录APP查看全文

猜你喜欢

血液透析疗效
止眩汤改良方治疗痰瘀阻窍型眩晕的临床疗效观察
冷喷联合湿敷甘芩液治疗日晒疮的短期疗效观察
中西医结合治疗慢性盆腔炎的疗效观察
综合护理干预对血液透析患者深静脉导管并发症的影响
低钠透析联合血液透析滤过对尿毒症合并顽固性高血压患者血压昼夜节律变化的影响
血液透析患者动静脉内瘘的护理体会
脐灸治疗脑卒中后便秘的疗效
破裂腹主动脉瘤的腔内修复术与开放手术疗效比较
针刺拉伸加TDP照射法治疗落枕的疗效报道